We review recently developed reference methods based on mass fragmentography (specific ion monitoring) with use of isotope-labeled internal standard, for determination of cholesterol, triglycerides, urea, glucose, cortisol, progesterone, and testosterone. With an optimal ratio between standard and material to be determined, the relative standard deviation of these methods, based on duplicate determinations, is between 1.3 and 2.7%. The very high specificity of the methods, in combination with the fact that the ratio between labeled and unlabeled molecules is determined with a high degree of accuracy, makes it likely that the most significant errors in the methods are related to errors in pipetting. The possibility is discussed that these methods might be developed into "absolute" or "definitive" methods by subjecting each individual step in the determination to a detailed analysis with respect to possible error. We also discuss some of the consequences of the different reference methods on the choice of routine methods. 
We review recently developed reference methods based on mass fragmentography (specific ion monitoring) with use of isotope-labeled internal standard, for determination of cholesterol, triglycerides, urea, glucose, cortisol, progesterone, and testosterone. With an optimal ratio between standard and material to be determined, the relative standard deviation of these methods, based on duplicate determinations, is between 1.3 and 2.7%. The very high specificity of the methods, in combination with the fact that the ratio between labeled and unlabeled molecules is determined with a high degree of accuracy, makes it likely that the most significant errors in the methods are related to errors in pipetting. The possibility is discussed that these methods might be developed into "absolute" or "definitive" methods by subjecting each individual step in the determination to a detailed analysis with respect to possible error. We also discuss some of the consequences of the different reference methods on the choice of routine methods. In scientific work a thigh accuracy is always necessary.
In routine work a decreased accuracy may sometimes be justified if it is sufficient for the diagnostic considerations and if the method saves considerable time and work as compared to a more nearly accurate method. In both cases, it should be of value to know the exact divergence from the "true" values. In spite of this, introduction of new methods that are introduced into clinical chemical routine are seldom validated by comparison with highly accurate reference methods. Rather, results of a new method for an analyte are usually compared with those of previously used routine methods for that analyte. If the difference by the two methods is not too marked, there is seldom any discussion concerning which of the two methods gives values that are closer to the true values. In the absence of a comparison of a new method with a highly accurate reference method, data concerning precision will be most important. The U. S. National Bureau of Standards (1) has pointed out that the values obtained by a precise but inaccurate method cannot and will not be sustained under legal challenge if values obtained by a method shown to be more nearly accurate are offered in evidence. Thus the method giving values that are "closer to truth" will always tend to carry more weight in legal arguments. To our knowledge, only one reference method has as yet been published that fuilfills all the requirements of an "absolute" reference method ("definitive" method) (1, 2) . With this method, which is based on mass spectrometry, calcium in serum can be determined to within ±2% of the "true" or "absolute" value.
During the last few years we have developed some reference methods based on mass fragmentography (specific ion monitoring) and isotope-labeled internal standards that seem to be more nearly accurate than most other reference methods previously used (3-9). Mass fragmentography with isotope-labeled internal standards has hitherto been used extensively in pharmacological research as well as in some biochemical research, but has only been used to a very limited extent in clinical chemistry. The basic principle is that the ratio between unlabeled molecules and molecules labeled with 2H, '3C, 14C, or 15N can be determined with high accuracy and precision with use of mass spectrometry.
The isotope-labeled molecules, of the same kind as the molecules that are to be determined, are added in a fixed amount to a fixed volume of serum or urine. After ex-traction and eventual chromatographic purification, the ratio between the molecules is determined with a mass spectrometer equipped with a MID (multiple-ion detector).2 Because the labeled molecules have a mass that differs from the unlabeled molecules only by a few mass units, the ratio between labeled molecules and unlabeled molecules cannot be changed during extractions and chromatography.
In the MID analysis there is little possibility of interference, because there is little chance for compounds to be present in the purified material that have both the same chromatographic properties as the material to be determined and the same specific ion in the mass spectrum. The presence of interference can easily be tested by using other ions in the MID analysis and by subjecting the material to different purification procedures before the MID analysis. Under optimal conditions, the most significant error in the method should be the error in the pipetting (maximum about 2%), and theoretically it should be possible to determine compounds by this method within 2-4% of the "true" or "absolute" value. Mass-fragmentographic methods have been developed in our laboratory for determination of serum cholesterol, triglycerides, urea, glucose, progesterone, testosterone, and cortisol in plasma. The details in all these methods have been published (3) (4) (5) (6) (7) (8) or will be published (9) elsewhere. In the case of determination of glucose, progesterone, and testosterone, mass-fragmentographic techniques had been described prior to our work (10) (11) (12) (13) . For different reasons, some of these previous techniques may be less suitable in connection with validation of routine methods in clinical chemistry if a very high accuracy is wanted. In the case of determination of steroid hormones, several authors have very recently pointed out that mass fragmentography may be used to validate different routine methods (11, 14, 15) . Except for the present work, however, only a few studies have been published in which routine methods and mass-fragmentographic methods have been compared directly (11) . In view of the recent discussion in this journal with respect to development of reference methods (16) (17) (18) (19) and in order to stimulate further use of such methods, it may be justified to review our reference methods briefly. Some of the published methods have been modified slightly and their specificity and accuracy have been tested by other means in the present work than in the original publications. It should clearly be pointed out that at the present state our reference methods cannot be regarded 
Materials and Methods Unlabeled Compounds
All the unlabeled compounds, except for progesterone, had an apparent purity of 99% or more. Progesterone had a purity of 98%. Details concerning the source of the compounds and the methods for estimation of purity are given in the original publications After evaporation of the solvent, the residue was converted into the dimethoxime-tri-(trimethylsilyl)
Labeled Compounds
derivative by treatment first with methoxylamine HC1 in pyridine and then with trimethylsilylimidazole.
The derivative was extracted from the mixture with hexane. The solvent was removed from the hexane phase under a stream of nitrogen at room temperature.
The residue was dissolved in a small volume of hexane before analysis by gas chromatography-mass spectrometry.
Progesterone determinations (6).
[4-'4C] Progesterone, 24 pmol, dissolved in acetone, was added to 1 ml of serum. After extraction with hexane and evaporation of the solvent, the residue was subjected to thin-layer chromatography.
The zone corresponding to [414C] progesterone was detected by radioscanning of the chromatographic plate with a Berthold DUnnschichtScanner II (Wildbad, G.F.R.). The progesterone was eluted from the silica gel with methanol.
After evaporation of the methanol, the residue was converted into the heptafluorobutyrate by treatment with heptafluorobutyric acid anhydride in acetone. The acetone was then evaporated and the residue dissolved in a small volume of hexane before analysis by gas chromatography-mass spectrometry.
Testosterone determinations (5).
[4-'4C]Testosterone, 35 pmol, dissolved in acetone, was added to 1 ml of serum and extracted with diethyl ether in the presence of 0.1 ml of aqueous sodium hydroxide solution (1 mol/liter). After evaporation of the solvent from the ether phase, the residue was subjected to thin-layer chromatography.
The zone corresponding to [4-'4C]-testosterone was detected by radioscanning with the same equipment as used above. After elution of the testosterone from the silica gel by methanol and evaporation of the solvent, the residue was converted into the trimethylsilyl derivative by treatment with tnmethylsilylimidazole.
The derivative obtained was extracted from the mixture with hexane. The solvent was removed from the hexane phase and the residue was dissolved in a small volume of hexane before analysis by gas chromatography-mass spectrometry.
Combined Gas Chromatography-Mass Spectrometry (Mass Fragmentography)
Combined gas chromatography-mass spectrometry was performed with an LKB 9000 instrument equipped with MID (multiple ion detector).
In all analyses, the electron energy was set to 20 eV and the trap current to 60 jA. The electron multiplier sensitivity was given values between 150 and 180. With the exception of some analyses of triglycerides and cholesterol, the same amplification was used for both the channels of the MIDunit that were used in the different analyses. The filter settings of the channels was 0.5 Hz and the measure time was 20 ms. The MID-recordings were made on uv-paper. The peak height of the recordings (in general, 100-200 mm) was measured, as this was found to give more reproducible results than measurement of peak area. In the gas-chromatography, 1 .5% SE-30, 3% SE-30, or 3% QF-1, were used. The carrier gas was helium and the flow rate was 15-30 ml/min. The temperature of the flash-heater and ion source was set at a temperature at least 40 #{176}C above the temperature of the column. The stability of the mass spectrometer was routinely tested by analyses of a sample every 2 h during 12 h. The coefficient of variation in the ratio between unlabeled molecules and labeled molecules was <1.5%. A prerequisite of such stability was that the magnetic field strength had to be fixed at the appropriate value a few hours before the analysis. It may be mentioned that other authors have not obtained such high stability when using the LKB 9000 instrument 
Routine Laboratory Procedures

Serum cholesterol
was determined by three different procedures:
(a) The Liebermann-Burchard reaction Plasma cortisol was determined by the fluorometnic procedure described by Mattingly (30) or by a competitive protein-binding method described by Murphy et al. (31) . In the latter determination we used a commercial kit from CIS (Cea Ire Sonin, Gif-Sur-Yvette, France) containing human transcortin and [1,2-3H2] cortisol. 100 where a and b are duplicates and n is the total number of determinations.
Results
Determination of Cholesterol by
Mass Fragmentography
The mass spectrum of unlabeled cholesterol and [2,2,3,4-2H4]cholesterol is shown in Figure 1 . It is evident that the labeled cholesterol mainly consists of tnand tetradeuterated molecules and that the molecular peak at m/e 386 in the mass spectrum of unlabeled cholesterol and at m/e 389 in the mass spectrum of labeled cholesterol are suitable in the mass fragmentographic analysis. Figure 2 shows derivatives of hydrolyzed extracts of different standard mixtures of unlabeled triglycerides together with 500 nmol of 1,1,2,3,3-2H5-labeled triglycerides was linear with increasing amounts of unlabeled triglycerides. Figure 5 shows a typical MID-recording of the tnmethylsilyl derivative of hydrolyzed purified serum to which labeled triglycerides had been added.
Determination of Urea by Mass Fragmentography (8)
Urea is very difficult to analyze by gas chromatography. In our hands, a published method for gas chromatography of urea (33) gave broad tailing peaks and a very low reproducibility.
In addition it was necessary to separate urea from other water-soluble compounds with similar properties that may interfere in the assay and such separation appeared to be difficult. Urea and the internal standard, [15N2jurea, were therefore converted into 5,5-diallyl barbituric acid with use of diallyl malonic acid diethyl ester. This compound could be separated from all interfering compounds by ion-pair extraction combined with methylation
The specificity of the method is obvious, since 5,5-diallyl barbitunic acid cannot be formed from any other serum constituents than urea in the presence of diallyl malonic acid diethyl ester. The molecular ions at rn/c 236 and m/e 238 in the mass spectrum of the dimethyl derivative of unlabeled and 15N2-labeled 5,5-diallyl barbituric acid, respectively, were chosen for the mass fragmentographic determinations (ci. Figure 6) 
Mass-fragmentographic determination of glucose was performed by determination of the ratio between unlabeled glucose molecules and hepta-deuterated molecules after conversion into the methoxime-penta-tni- No purification was found to be necessary before the analysis. The base peak in the mass spectrum of unlabeled methoxime-penta-tnimethylsilyl derivative of glucose is at rn/c 319 corresponding to carbon atoms 3-6 (18) . Corresponding peaks were seen in the mass spectrum of the same derivative of hepta-deuterated glucose at rn/c 322 and rn/c 323 (Figure 8 ). It was calculated that the fragment contained 93% tetra-deuterated molecules and 7% tri-deuterated molecules. Under the conditions used, the ratio between the peaks at rn/c 319 and rn/c 323 in the mass-fragmentographic recordings of different standard mixtures of unlabeled glucose together with 0.3 imol of deuterated glucose was linear with the amount of glucose added up to 30 mmol/liter. Use of the ions at rn/c 205 and rn/c 208 gave exactly the same results as use of the ions at rn/c 319 and 323. Analysis of serum samples to which no deutenated glucose had been added gave the same ratio between the tracings at rn/c 319 and rn/c 323 as analysis of unlabeled glucose. Figure 9 shows a typical MID recording of derivative of serum to which hepta-deuterated glucose had been added.
Determination of Cortisol by Mass Fragmentography (4)
Mass-fragmentographic determination of cortisol was performed by determination of the ratio between unlabeled cortisol molecules and 14C-labeled cortisol after conversion to the di-methoxime-tri-(tnimethylsilyl) derivative.
No purification before the analysis was found to be necessary. It should be pointed out that the possibility of interference in a mass fragmentographic determination decreases with increasing mass of the fragment used in the assay. The were used in the assay (cf. Figure 10) . When using the ions at rn/c 636 and rn/c 638 (corresponding to the molecular ions) we obtained identical results. Because the intensities of the molecular ions were considerably lower than the intensities of the ions corresponding to the M-31, the latter ions were preferred in the assay. Analysis of serum samples to which no [4-14C]cortisol had been added gave the same ratio between the tracings at rn/c 605 and 607 as did unlabeled cortisol, indicating that no other compounds in serum interfere significantly with the assay. The ratio between the peaks at rn/c 605 and rn/c 607 obtained in MID recordings from extracts of different standard mixtures of unlabeled cortisol with 552 pmol (200 ng) of [4-'4Cjcortisol increased with increasing amounts of unlabeled cortisol, but the increase was not linear with the amount of unlabeled contisol. This is due to the fact that unlabeled cortisol contributes to the recording at rn/c 607. After correction for these known contributions, however, the ratio between the peaks at rn/c 605 and 607 was linear with the amount of unlabeled cortisol. As a consequence of the overlapping, the range within which unlabeled cortisol could be determined with a high precision was relatively narrow as compared with the methods for determination of cholesterol, triglycerides, and urea. Figure 11 shows a typical MID recording of a serum extract to which [4-14C]cortisol had been added. were used in the assay. Since practically no other ions were seen in the mass spectra, it was not possible to check the specificity of the method with other ions in the same compound. If the same purified serum extract was analyzed by conversion of progesterone into the tnifluoroacetic acid derivative and use of the ions at rn/c 410 and rn/c 412, the same results were obtained as when we used the heptafluorobutyric acid derivative and the ions at rn/c 510 and 512. Analysis of serum samples to which no [4-'4C]progesterone had been added gave the same ratio between the tracings at rn/c 510 and 512 as in unlabeled progesterone.
As in the case of determination of cortisol, the ratio between the tracings at rn/c 510 and rn/c 512 was not linearly related to the amount of unlabeled progesterone when we analyzed extracts of different standard mixtures of unlabeled progesterone with 24 pmol (7.5 ng) of [4-'4C]progesterone.
As in the case of determination of cortisol, however, the standard curve became linear after correction for the contribution of the labeled compound to the tracing at rn/c 510 and the contribution of the unlabeled compound to the tracing at rn/c 512.
Determination of Serum Testosterone by Mass Fragmentography (5)
Mass-fragmentographic determination of testosterone was performed by determination of the ratio between unlabeled testosterone and [4-14C]testosterone after purification by thin-layer chromatography and conversion into the trimethylsilyl derivative. The intense molecular ions at rn/c 432 and 434, respectively, were used in the assay. Identical results were obtained when using the heptafluorobutyrate derivative and the Details concerning the different additions are given in references 3-9.
b Calculated from duplicate determinations of the same serum (cf. Statistics).
c With an optimal ratio between unlabeled urea and [T5N2Jurea (0.5-1.5) the relative standard deviation was Only 2.5%. < With an optimal ratio between unlabeled cortisoi and 14-'4C]cortisoi the relative standard deviation was only 2.2%. After correction for the contribution of the labeled compound to the tracing at rn/c 432 and the contribution of the unlabeled compound to the tracing at rn/c 434, the ratio between the two tracings was linearly related to the amount of unlabeled testosterone when we analyzed extracts of different standard mixtures of unlabeled testosterone together with 35 pmol (10 ng) of [4-14C]testosterone.
Accuracy and Precision of the Different MID Methods
We assessed the accuracy of the different MID techniques by adding known amounts of the compound to be determined to a serum containing a known concentration of the specific compound. Details concerning the different additions are given in publications 3-9. In Table 1 , the results of the analytical recovery experiments are summarized.
The maximum error was in general about 3%, but about 5% in the case of recovery experiments with cholesterol esters. This may be in part due to impurities in the cholesterol esters that could not be detected in the thin-layer chromatography used to validate purity. The relative standard deviation as calculated from duplicate determinations was less than 3% in the case of determination of cholesterol, triglycerides, glucose, and testosterone, and between 3 and 4% in the case of determination of urea, cortisol, and progesterone. In the case of determination of urea, cortisol, and progesterone, however, the difference between the mass of the unlabeled compound and the internal standard used in the MID determination was only 2. Under such conditions the range within which a high precision can be expected is narrow. By selecting serum samples that had a ratio between unlabeled compound and labeled internal standard of 0.5 to 1.5, a relative standard deviation of less than 3% was obtained.
Comparisons between the Mass Fragmentographic Methods and the Routine Methods Table 2 summarizes results of comparisons between the different MID methods and the different routine methods. Details concerning all the comparisons are given in references 3-9. Except for the progesterone determination, the testosterone determination, and the determination of cortisol by fluorometry, the correlation coefficient obtained in all the comparisons was greater than 0.95.
Discussion Limitations in the Present MassFragmentographic Methods
It may be appropriate to discuss some of the limitations and difficulties of the different mass fragmentographic methods presented here.
In the determination of cholesterol it can be argued that the isotope-labeled standard as well as the material used in the preparation of the standard curve was underivatized cholesterol.
A mixture of underivatized cholesterol and fatty acid esters of cholesterol of a composition similar to that in human plasma would have been preferred. It was clearly shown, however, that essentially the same results were obtained in recovery experiments, regardless of whether free cholesterol or cholesterol esters were used. Still, the possibility cannot be completely excluded that under some conditions a very small amount of the cholesterol esters may never be hydrolyzed in the procedure. a In the first 10 equations, the unit is mmol/Iiter. In the last five equations, the unit is nmol/liter.
In the determination of triglycerides a mixture of saturated and unsaturated glycerides was used as standard, with a fatty acid composition similar to that present in mammalian fat. However, the intramolecular distribution of fatty acids in mammalian fat is different from that of the standard. Under the conditions used, with an apparently complete clevage of the triglycerides, this should be of little or no importance in the assay. A problem in the present assay of triglycerides is the fact that the organic solvents used in the assay often contain traces of glycerol, which are difficult to remove. The solvents used in the present work had glycerol concentrations of less than 0.1 id/liter and could not influence the results. If the amount of standard and serum was decreased 10-fold, however, the small amount of glycerol in the solvents affected the results to a detectable degree.
A problem in the determination of urea was the finding that the degree of conversion into 5,5-diallyl #{149}barbituric acid varied considerably with different samples of serum, thus affecting the peak heights in the recordings. There are no reasons to believe, however, that different recoveries in the synthetic step may affect the ratio between labeled and unlabeled molecules. The variations in the yield of barbiturate could always be compensated for by varying the amount of sample injected, and it was clearly shown that the amount of sample injected had no influence on the ratio between the two recordings. It should be pointed out that if a patient has a therapeutic concentration of 5,5-diallyl barbituric acid in his blood, this may affect the values obtained with the MID-method. The interference should be slight, but cannot be calculated exactly in view of the varying yield in the reaction of urea with diallyl malonic acid diethyl ester. Interference of this kind can be avoided by using a derivative of malonic acid ester that gives a barbiturate that is not used clinically.
The problems in the assay of cortisol with the MID method are related to the small relative difference in mass between the ions at rn/c 605 and rn/c 607 and the fact that there is a considerable overlapping between unlabeled and labeled cortisol in the two channels. Thus there is a great need for stability of the magnetic field during the assay, and the range within which a precise determination can be obtained is relatively narrow. These problems may be overcome by using isotopelabeled cortisol with a mass more than two units higher than unlabeled cortisol. Introduction of more than two atoms of deuterium into cortisol is difficult, and several attempts to synthesize such material in our laboratory have failed. The fact that the labeled standard in the assay is radioactive cannot be regarded as a serious problem, although a stable-isotope-labeled cortisol would have been preferred in the assay. Most of the radioactivity injected into the gas-chromatographic column is accumulated in the oil in the pump system in the mass spectrometer and cannot be a risk for the people involved in the analysis. However, the oil should be changed more frequently than usual. (12, 14, 15) .
Also in the case of mass fragmentography of progesterone and testosterone the problems in the assay are related to the fact that there is some overlapping between the channel used for detection of the unlabeled compound and the channel used for detection of the labeled compound. This problem can be overcome by using an isotope-labeled standard with a molecular weight that is more than two mass units higher than that of the unlabeled material. In determination of progesterone and testosterone by mass fragmentography, use of a radioactive standard was advantageous because the radioactivity facilitated detection of the appropriate chromatographic zone in the thin-layer chromatography used for purification of the compound.
Limitations in Some Previously Developed
Mass-Fragmentographic Techniques
Mass-fragmentographic techniques have been developed without use of internal standards (36, 37) . It is evident that such techniques are less suited when a very high degree of accuracy is needed. Mass-fragmentographic techniques have also been developed in which an internal standard silylated with deuterated reagent is added to an extract of serum or urine (38) (39) (40) . With such a technique, uncertainties in the extraction are not compensated for. In addition, the silylated reagent used has such a high molecular weight as compared to the unlabeled reagent that there may be a partial separation of the labeled and unlabeled compound in the gaschromatography.
As a consequence, there may be different degree of adsorbance on the column and the two compounds may not be detected at the same time. Methylated steroids have been used as internal standards in some procedures (11, 41, 42) , but such internal standards may not behave identically with the steroid to be determined in the extraction procedure. Furthermore, also in this case, there is a more or less complete separation of the two steroids in the gas chromatography with a possibility of a different degree of adsorption on the column.
In all the above techniques referred to, a single or multiple ion detector has been used. Repetitive scanning during the gas chromatography, giving complete or partial mass spectra and later reconstruction of single ion chromatograms (43, 44) , may also be used in quantitative work. Under optimal conditions such a technique has a sensitivity sufficient for most of the determinations reviewed above (ci. 45). The accuracy of such a technique should also be high, in particular when one is scanning over a very limited mass range and using an internal standard with a mass that is only a few mass units higher than the compound to be detected. In our hands, however, the relative standard deviation has been consistently somewhat higher with repetitive scanning than with specific ion monitoring.
Specificity, Accuracy, and Precision
The most characteristic property of the techniques presented is their high specificity. To interfere with the assay, a compound must have the same gas-chromatographic behavior and contain the same specific ion in its mass spectrum as the compound to be determined. In the case of the present determination of triglycerides, progesterone, and testosterone, interference by a certain compound also requires that it has the same thin-layer chromatographic properties as the compound to be determined. The occurrence of interference could easily be tested by using other ions in the mass spectrum for quantitation, which should give the same result if there is no interference.
It may be added that the possibility of interference must decrease with increasing mass number of the fragment chosen. As a consequence, the need for purification before analysis must also decrease with increasing mass number of the fragment. Occurrence of interfering compounds in the serum may in some cases be detected by comparing the ratio between the tracings in the two channels after analysis of a serum extract and after analysis of the pure compound to be determined. The same ratio should be obtained in both cases if there is no interference.
In the present work, the maximum difference between the mass of the labeled compound and the compound to be determined was 7 mass units. If the difference in mass is considerably higher, the labeled compound often has a different retention time on gasliquid chromatography from that of the unlabeled compound. In the analysis of small amounts of material, adsorption to the column material may be important and differences in retention time may give differences in the degree of adsorption of labeled and unlabeled material.
We tested the accuracy of the techniques by adding known amounts of the material to be determined to serum with a known concentration of the same compound. However, a successful recovery experiment of this type does not per sc completely rule out possible interference in the assay of the endogenous compound. This should particularly be kept in mind in the evaluation of radioimmunoassay techniques. With an optimal ratio between standard and material to be determined, the precision of the present techniques was high and the standard deviation as determined from duplicate samples was less than 3%. It seems probable that pipetting errors are the most sig-nificant source of the variation. Instability of the mass spectrometer during the determinations may also be significant (cf. Methods).
Evaluation of Routine Methods by Use of Mass Fragmentography
We have given some examples of how the reference methods can be used for evaluation of routine methods. From the results obtained it is evident that the enzymatic method for determination of cholesterol as well as the modified Pearson method has certain merits as compared to the Liebermann-Burchard method. The best method of those tested for glucose determination was the glucose oxidase method with determination of rate of oxygen consumption, but this method is not suitable in some routine work with a great number of samples. There was only a small difference between results by the reference method and the glucose oxidase-dicarboxidine method and between the reference method and the two hexokinase methods. The accuracy and precision of the simple dipstick method for determination of glucose was surprisingly high. In our hands, the fluorometric method for determination of cortisol was much less accurate than the competitive proteinbinding method. The routine methods for determination of triglycerides, urea, and testosterone are sufficiently accurate for most purposes. In the case of determination of progesterone it was shown that one of the radioimmunoassay methods gave values up to twice those by the reference method.
Mass-Fragmentographic Methods in Clinical Research
Many routine methods are insufficiently specific for research work. In the case of determination of progesterone the marked difference between results by the mass-fragmentographic method and one of the radioimmunoassay methods may be of little importance if the clinical question is only to define the time for appearance of the progesterone peak in the menstrual cycle. However, such a routine method evidently cannot be used in (e.g.) a recent research project carried out at our laboratory in which the effect of ethanol on different #{149} hormones was studied. Another reason for using highly specific methods in many clinical research projects is the direct interference of many drugs on laboratory tests. There is an immense literature concerning such interferences (46).
Mass Fragmentography for Developing "Definitive" Reference Methods in Clinical Chemistry?
The reference methods suggested here are more specific than are most other previously published reference methods. As is evident from the above considerations, most of the limitations of the methods can be eliminated or at least decreased. With slight modifications and an extensive analysis of possible errors in each individual step it should be possible to develop these methods into "definitive" or "absolute" methods.
Note added in proof. After acceptance of the present work, mass-fragmentographic reference methods for determination of serum cholesterol and serum testosterone, similar to those reviewed here, have been published (47, 48). In both cases, comparisons were made between the results of the reference method and a routine method. Very recently also, a mass-fragmentographic reference method for determination of inorganic phosphate was published (49).
